Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 7Polycystic Ovary Syndrome 4Prostatic Neoplasms 2Carcinoma, Intraductal, Noninfiltrating 2Rectal Neoplasms 1Psoriasis 1Precancerous Conditions 1Peripheral Nervous System Diseases 1Pain 1Ovarian Neoplasms 1Osteoarthritis 1Obesity 1Neoplasms 1Neoplasm, Residual 1Multiple Sclerosis 1Lipid Metabolism Disorders 1Inflammation 1Healthy Subject 1Dyspareunia 1Diabetes Mellitus 1Crohn Disease 1Cardiovascular Diseases 1Breast Neoplasms, Male 1Breast Feeding 1Breast Carcinoma In Situ 1Autoimmune Diseases 1Arthritis, Rheumatoid 1Aggressive Periodontitis 1

Interventions

Fluorouracil 155Oxaliplatin 133Leucovorin 124Capecitabine 90Irinotecan 88Radiotherapy 63Bevacizumab 61Cetuximab 38Folfox protocol 25Panitumumab 21Neoadjuvant Therapy 21Surgical Procedures, Operative 19Chemotherapy, Adjuvant 15Radiation 13Floxuridine 13Erlotinib Hydrochloride 13Early Intervention, Educational 13IFL protocol 11Drug Therapy 11Proctectomy 10Magnetic Resonance Spectroscopy 10Counseling 10Surveys and Questionnaires 8Sorafenib 8Psychiatric Rehabilitation 8Gene Expression Profiling 8Radiotherapy, Intensity-Modulated 7Immunohistochemistry 7Gemcitabine 7Celecoxib 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Rectal Neoplasms × Fish Oils × Clear all
NCT02534389 2017-02-09

Fish Oil Supplement in Rectal Cancer

AC Camargo Cancer Center

Phase NA Completed
100 enrolled
Gastrointestinal

Inflammation, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡